Sur cette page
PCRX Pacira BioSciences, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 4, 2026
$25,21
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$18,80Bas 52 semaines
$27,66Haut 52 semaines
Capitalisation Boursière (MRQ)
$1.00B
P/E (TTM)
70.0
BPA (TTM)
$0.36
Revenu (TTM)
$746M
vos badges
Fourchette 52 semaines
$19–$28
Note des analystes
BUY
Objectif de cours
$30
P/E
70.0
ROE
2.0%
Marge nette
2.0%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
PCRX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$25.21
Capitalisation Boursière (MRQ)
$1.00B
P/E (TTM)
70.0
BPA (TTM)
$0.36
Revenu (TTM)
$746M
ROE (TTM)
2.0%
Dette/Capitaux propres (MRQ)
0.5
Fourchette 52 semaines
$19–$28
PCRX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$726M2016-12-31 → 2025-12-31
BPA$0.162016-12-31 → 2025-12-31
Flux de trésorerie libre$137M2016-12-31 → 2025-12-31
Marge nette2.0%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | PCRX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 70.0moyenne 5 ans ≈74.0 | ≈74.0 | · | · | |
| P/S (TTM) | 1.3moyenne 5 ans ≈2.5 | ≈2.5 | · | · | |
| P/B (MRQ) | 1.5moyenne 5 ans ≈2.1 | ≈2.1 | 3.7 | Sous-évalué | |
| EV / EBITDA (TTM) | 10.6 | · | · | · | |
| Cours / FCF (TTM) | 5.6moyenne 5 ans ≈14.6 | ≈14.6 | · | · | |
| Cours / Flux de trésorerie (TTM) | 5.3moyenne 5 ans ≈11.1 | ≈11.1 | · | · | |
| VE / Chiffre d'affaires (TTM) | 1.5 | · | · | · | |
| VE / FCF (TTM) | 6.2 | · | · | · | |
| Cours / Actif net tangible (MRQ) | 2.6moyenne 5 ans ≈9.5 | ≈9.5 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | PCRX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | 2.7%moyenne 5 ans ≈10.3% | ≈10.3% | -2342.9% | Premier rang | |
| Marge EBITDA (TTM) | 14.1%moyenne 5 ans ≈21.0% | ≈21.0% | -1487.9% | Premier rang | |
| Marge avant impôts (TTM) | 2.4%moyenne 5 ans ≈6.0% | ≈6.0% | -414.1% | Premier rang | |
| Marge nette (TTM) | 2.0%moyenne 5 ans ≈4.3% | ≈4.3% | -1320.1% | Premier rang | |
| ROA (TTM) | 1.1%moyenne 5 ans ≈0.01% | ≈0.01% | -34.1% | Premier rang | |
| ROE (TTM) | 2.0%moyenne 5 ans ≈0.14% | ≈0.14% | -39.7% | Premier rang | |
| ROIC | 0.75%moyenne 5 ans ≈2.2% | ≈2.2% | -30.5% | Premier rang |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | PCRX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Dette / Capitaux propres (MRQ) | 0.5 | · | 0.3 | Endettement élevé | |
| Ratio de liquidité (MRQ) | 5.0moyenne 5 ans ≈3.4 | ≈3.4 | 10.1 | Faible liquidité | |
| Ratio de liquidité réduite (MRQ) | 3.1moyenne 5 ans ≈2.6 | ≈2.6 | 9.0 | Faible liquidité | |
| Dette à long terme / Capitaux propres (MRQ) | 0.5 | · | 0.3 | Endettement élevé |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | PCRX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 3.6%moyenne 5 ans ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 2.9%moyenne 5 ans ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 11.1% | · | · | · | |
| EPS YoY (BPA Année/Année) | 161.8%moyenne 5 ans ≈8.8% | ≈8.8% | · | · | |
| Net Income YoY (Bénéfice net YoY) | 163.7%moyenne 5 ans ≈10.2% | ≈10.2% | · | · | |
| EPS CAGR 3Y (TCAC BPA 3 ans) | -22.2% | · | · | · | |
| EPS CAGR 5Y (TCAC BPA 5 ans) | -45.5% | · | · | · | |
| Net Income CAGR 3Y (TCAC Bénéfice net 3 ans) | -23.8% | · | · | · | |
| Net Income CAGR 5Y (TCAC Bénéfice net 5 ans) | -45.4% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | PCRX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.5moyenne 5 ans ≈0.4 | ≈0.4 | 0.2 | Premier rang | |
| Inventory Turnover (Rotation des stocks) | 1.1moyenne 5 ans ≈1.6 | ≈1.6 | · | · | |
| Receivables Turnover (Rotation des créances) | 6.1moyenne 5 ans ≈6.7 | ≈6.7 | 11.6 | Faible | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$880.5K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-2.3%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 3, 2026 | $0.73 | $0.66 | 10.6% |
| 31 mars 2026 | Mai 6, 2026 | $0.60 | $0.57 | 4.4% |
| 31 décembre 2025 | $0.57 | $0.92 | -38.2% | |
| 30 septembre 2025 | $0.70 | $0.66 | 5.3% | |
| 30 juin 2025 | $0.74 | $0.72 | 2.1% | |
| 31 mars 2025 | $0.62 | $0.61 | 2.0% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Cost of Revenue | $150M | $170M | $185M | $199M | $140M | $117M | $107M | $87M | $88M | $110M | $72M | $77M | |
| R&D Expense | $117M | $82M | $76M | $85M | $56M | $59M | $72M | $56M | $57M | $46M | $29M | $19M | |
| SG&A Expense | $369M | $294M | $269M | $255M | $199M | $194M | $201M | $177M | $161M | $153M | $139M | $107M | |
| Operating Expenses | $707M | $774M | $587M | $607M | $452M | $383M | $411M | $321M | $312M | $308M | $240M | $203M | |
| Operating Income | $19M | $-73M | $88M | $60M | $90M | $46M | $10M | $16M | $-25M | $-32M | $9M | $-5M | |
| Interest Expense | · | · | $20M | $40M | $32M | $26M | $24M | $22M | $18M | $7M | $8M | $8M | |
| Interest Income | $23M | $20M | $11M | $5M | $896.0K | $5M | $7M | $6M | $4M | $1M | $678.0K | $382.0K | |
| Other Non-op | $-7M | $-373.0K | $-186.0K | $-11M | $-3M | $3M | $-5M | $-888.0K | $167.0K | $-82.0K | $-165.0K | $-159.0K | |
| Pretax Income | $17M | $-63M | $62M | $13M | $56M | $20M | $-11M | $-425.0K | $-42M | $-38M | $2M | $-14M | |
| Income Tax | $10M | $36M | $20M | $-3M | $14M | $-125M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $173.0K | |
| Net Income | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| EPS (Basic) | $0.16 | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.05 | $-0.39 | |
| EPS (Diluted) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 | |
| Shares (Basic) | 44,566,000 | 46,245,000 | 46,222,000 | 45,521,000 | 44,262,000 | 42,671,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 36,540,000 | 35,299,000 | |
| Shares (Diluted) | 45,042,000 | 46,245,000 | 51,979,000 | 46,538,000 | 45,630,000 | 43,682,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 41,301,000 | 35,299,000 | |
| EBITDA | $110M | $5M | $163M | $152M | $118M | $66M | $30M | $29M | $-11M | $-19M | $21M | $5M |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $277M | $153M | $104M | $586M | $100M | $78M | $133M | $54M | $36M | $54M | $38M | |
| Short-term Investments | $80M | $208M | $125M | $185M | $71M | $422M | $214M | $251M | $257M | $137M | $102M | $119M | |
| Receivables | $124M | $113M | $106M | $98M | $96M | $53M | $48M | $38M | $32M | $30M | $26M | $22M | |
| Inventory | $153M | $125M | $104M | $96M | $99M | $65M | $58M | $49M | $41M | $31M | $62M | $29M | |
| Prepaid Expense | $33M | $22M | $22M | $15M | $15M | $12M | $11M | $8M | $7M | $9M | $6M | $4M | |
| Current Assets | $548M | $745M | $510M | $498M | $866M | $652M | $409M | $478M | $391M | $243M | $253M | $214M | |
| PP&E (Net) | $141M | $167M | $174M | $184M | $188M | $137M | $105M | $109M | $107M | $101M | $90M | $61M | |
| PP&E (Gross) | $278M | $300M | $309M | $301M | $274M | $215M | $180M | $170M | $156M | $139M | $115M | $81M | |
| Accum. Depreciation | $138M | $133M | $135M | $117M | $85M | $78M | $75M | $62M | $49M | $38M | $25M | $20M | |
| Goodwill | $20M | $0 | $163M | $163M | $145M | $100M | $100M | $62M | $55M | $47M | $31M | $24M | |
| Intangibles | $368M | $426M | $483M | $541M | $624M | $97M | $104M | $0 | · | $0 | $81.0K | $403.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $657.0K | $825.0K | $624.0K | $406.0K | $3M | |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Accounts Payable | $15M | $19M | $16M | $15M | $11M | $10M | $13M | $14M | $15M | $8M | $9M | $7M | |
| Accrued Liabilities | $96M | $80M | $64M | $90M | $128M | $71M | $70M | $46M | $41M | $37M | $35M | $28M | |
| Current Liabilities | $121M | $310M | $97M | $148M | $521M | $253M | $108M | $61M | $56M | $45M | $150M | $140M | |
| Capital Leases | $36M | $45M | $55M | $65M | $72M | $71M | $41M | $0 | · | · | · | · | |
| Deferred Tax | $4M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $21M | $17M | $14M | $10M | $20M | $4M | $2M | $17M | $16M | $19M | $11M | $5M | |
| Total Liabilities | $572M | $775M | $704M | $906M | $1.34B | $655M | $476M | $368M | $349M | $172M | $169M | $155M | |
| Long-term Debt | $372M | $585M | $522M | $689M | · | · | · | · | · | $109M | $104M | $103M | |
| Total Debt | $372M | · | · | · | · | · | · | · | · | $119M | $119M | $120M | |
| Common Stock | $48.0K | $47.0K | $46.0K | $46.0K | $45.0K | $44.0K | $42.0K | $41.0K | $41.0K | $37.0K | $37.0K | $36.0K | |
| Paid-in Capital | $1.06B | $1.01B | $977M | $924M | $942M | $873M | $754M | $710M | $669M | $565M | $527M | $481M | |
| Retained Earnings | $-199M | $-206M | $-107M | $-149M | $-212M | $-254M | $-399M | $-388M | $-389M | $-346M | $-308M | $-310M | |
| Treasury Stock | $177M | $25M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $4M | $343.0K | $247.0K | $-380.0K | $167.0K | $318.0K | $322.0K | $-280.0K | $-454.0K | $-30.0K | $-52.0K | $-80.0K | |
| Stockholders' Equity | $693M | $778M | $870M | $775M | $730M | $620M | $355M | $321M | $279M | $219M | $218M | $171M | |
| Liabilities + Equity | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Shares Outstanding | 41,116,739 | 47,078,000 | 46,481,000 | 45,928,000 | 44,734,000 | 43,637,000 | 41,908,148 | 41,222,799 | 40,668,877 | 37,480,952 | 36,848,319 | 36,150,620 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $79M | $76M | $92M | $29M | $20M | $20M | $13M | $14M | $13M | $11M | $10M | |
| Stock-based Comp | $58M | $51M | $48M | $48M | $42M | $40M | $34M | $32M | $32M | $31M | $33M | $25M | |
| Deferred Tax | $6M | $21M | $16M | $-8M | $11M | $-127M | $-2M | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $57M | $57M | $57M | $57M | $14M | $8M | $6M | $0 | $0 | $100.0K | $300.0K | $800.0K | |
| Restructuring | $4M | $9M | $1M | $0 | $0 | $-38.0K | $847.0K | $2M | · | · | · | · | |
| Other Non-cash | $-10M | $138M | $-26M | $-2M | $2M | $-2M | $30M | $4M | $15M | $27M | $-18M | $4M | |
| Operating Cash Flow | $152M | $189M | $155M | $145M | $126M | $77M | $71M | $49M | $18M | $33M | $28M | $27M | |
| CapEx | $15M | $11M | $15M | $30M | $46M | $38M | $10M | $15M | $19M | $25M | $40M | $23M | |
| Investing Cash Flow | $99M | $-83M | $78M | $-225M | $-21M | $-278M | $-128M | $21M | $-224M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | · | |
| Stock Repurchased | $148M | $25M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-148M | $-25M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-370M | $17M | $-183M | $-402M | $381M | $222M | $4M | $9M | $224M | · | · | · | |
| Net Change in Cash | $-118M | $123M | $49M | $-481M | $486M | $22M | $-54M | $78M | · | · | · | · | |
| Taxes Paid | $9M | $11M | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M | $39M | $60M | $34M | $-1M | $9M | $-12M | $4M | |
| Levered FCF | · | · | $126M | $67M | $56M | $-147M | $36M | $10M | $-20M | $2M | $-19M | $-5M |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.6% | · | 13.0% | 9.0% | 16.6% | 10.8% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -2.6% | |
| Net Margin | 0.97% | · | 6.2% | 2.4% | 7.8% | 33.9% | -2.6% | -0.14% | -14.9% | -13.7% | 0.75% | -6.9% | |
| Pretax Margin | 2.3% | · | 9.1% | 2.0% | 10.4% | 4.7% | -2.5% | -0.13% | -14.8% | -13.7% | 0.85% | -6.9% | |
| EBITDA Margin | 15.2% | · | 24.2% | 22.7% | 21.9% | 15.4% | 7.1% | 8.6% | -3.9% | -6.9% | 8.4% | 2.5% | |
| ROA | 0.50% | -6.4% | 2.6% | 0.85% | 2.5% | 13.8% | -1.5% | -0.07% | -8.4% | -9.7% | 0.52% | -5.5% | |
| ROE | 0.97% | -13.0% | 4.9% | 2.1% | 5.8% | 24.2% | -3.1% | -0.15% | -17.1% | -17.3% | 0.95% | -12.9% | |
| ROIC | 0.75% | -14.9% | 6.9% | 9.3% | 9.2% | 54.2% | 3.0% | 5.5% | -8.9% | -9.5% | 2.5% | -1.8% |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 | 2.6 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 | 2.3 | 3.2 | 6.9 | 6.1 | 4.5 | 1.2 | 1.3 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.7 | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 4.3 | 1.5 | 2.8 | 1.8 | 0.4 | 0.7 | -1.4 | -4.5 | 1.2 | -0.6 |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | |
| Inventory Turnover | 1.1 | 1.5 | 1.8 | 2.0 | 1.7 | 1.9 | 2.0 | 1.9 | 2.4 | 2.4 | 1.6 | 3.5 | |
| Receivables Turnover | 6.1 | · | 6.6 | 6.8 | 7.3 | 8.5 | 9.8 | 9.7 | 9.3 | 9.9 | 10.3 | 10.7 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.86 | $16.83 | $18.72 | $16.87 | $16.33 | $14.20 | $8.47 | $7.79 | $6.87 | $5.84 | $5.93 | $4.73 | |
| Revenue / Share | $16.13 | · | $12.99 | $14.33 | $11.87 | $9.84 | $10.14 | · | $7.20 | $7.42 | $6.03 | · | |
| Cash Flow / Share | $3.37 | $4.10 | $2.98 | $3.12 | $2.76 | $1.76 | $1.70 | · | $0.45 | $0.90 | $0.70 | · | |
| Cash / Share | $3.86 | $5.99 | $3.30 | $2.27 | $13.09 | $2.29 | $1.87 | $3.21 | $1.33 | $0.96 | $1.55 | $1.04 | |
| EPS (TTM) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.6% | 3.9% | 1.2% | 23.1% | 26.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.9% | 9.0% | 16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 161.8% | -63.0% | -72.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.2% | · | -35.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 163.7% | -62.1% | -71.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | -33.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Net Income TTM | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| Market Cap | $1.06B | $871M | $1.57B | $1.77B | $2.69B | $2.61B | $1.90B | $1.77B | $1.86B | $1.21B | $2.83B | $3.21B | |
| Enterprise Value | $1.20B | · | · | · | · | · | · | · | · | $1.16B | $2.79B | $3.17B | |
| P/E | 161.8 | -8.8 | 37.9 | 113.6 | 65.4 | 18.0 | -167.8 | -4302.0 | -42.7 | -31.7 | 1919.8 | -227.3 | |
| P/S | 1.5 | 1.2 | 2.3 | 2.7 | 5.0 | 6.1 | 4.5 | 5.3 | 6.5 | 4.4 | 11.4 | 16.2 | |
| P/B | 1.5 | 1.1 | 1.8 | 2.3 | 3.7 | 4.2 | 5.3 | 5.5 | 6.6 | 5.5 | 13.0 | 18.7 | |
| P / Tangible Book | 3.5 | 2.5 | 7.0 | 24.9 | · | 6.2 | · | · | · | · | · | · | |
| P / Cash Flow | 7.0 | 4.6 | 10.1 | 12.2 | 21.4 | 33.9 | 26.9 | 36.3 | 104.4 | 36.2 | 97.6 | 125.8 | |
| P / FCF | 7.8 | 4.9 | 11.2 | 15.4 | 33.7 | 66.6 | 31.5 | 51.6 | -1253.6 | 138.5 | -230.5 | 895.3 | |
| EV / EBITDA | 10.9 | · | · | · | · | · | · | · | · | -60.5 | 133.3 | 650.6 | |
| EV / FCF | 8.8 | · | · | · | · | · | · | · | · | 132.3 | -227.2 | 885.0 | |
| EV / Revenue | 1.6 | · | · | · | · | · | · | · | · | 4.2 | 11.2 | 16.0 | |
| Earnings Yield | 0.62% | -11.4% | 2.6% | 0.88% | 1.5% | 5.6% | -0.60% | -0.02% | -2.3% | -3.2% | 0.05% | -0.44% |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $177M | $197M | $180M | $181M | $169M | $187M | $169M | $178M | $167M | $181M | $164M | $169M | $160M | · | $167M | |
| Cost of Revenue | $44M | $36M | $40M | $34M | $41M | $34M | $40M | $39M | $44M | $47M | $48M | $40M | $48M | $49M | $62M | $51M | |
| R&D Expense | $30M | $28M | $38M | $26M | $28M | $25M | $24M | $19M | $20M | $18M | $19M | $21M | $19M | $17M | $18M | $19M | |
| SG&A Expense | $92M | $94M | $102M | $92M | $89M | $87M | $80M | $74M | $68M | $72M | $66M | $68M | $65M | $71M | $64M | $61M | |
| Operating Expenses | $188M | $170M | $195M | $173M | $173M | $167M | $163M | $308M | $150M | $154M | $148M | $146M | $130M | $163M | · | $146M | |
| Operating Income | $4M | $7M | $2M | $6M | $8M | $2M | $25M | $-140M | $28M | $13M | $33M | $18M | $40M | $-3M | $-10M | $21M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $4M | $10M | · | $10M | |
| Interest Income | $2M | $2M | $2M | $9M | $5M | $7M | $6M | $5M | $5M | $4M | $3M | $3M | $2M | $3M | $3M | $1M | |
| Other Non-op | $-34.0K | $-135.0K | $-172.0K | $-110.0K | $-11M | $4M | $-53.0K | $-122.0K | $-39.0K | $-159.0K | $515.0K | $-422.0K | $-269.0K | $-10.0K | $81.0K | $-11M | |
| Pretax Income | $3M | $5M | $571.0K | $10M | $-2M | $9M | $26M | $-139M | $37M | $14M | $34M | $17M | $38M | $-26M | $-18M | $2M | |
| Income Tax | $-2M | $2M | $-1M | $4M | $3M | $4M | $9M | $5M | $18M | $5M | $9M | $6M | $12M | $-7M | $-8M | $3M | |
| Net Income | $5M | $3M | $2M | $5M | $-5M | $5M | $16M | $-143M | $19M | $9M | $25M | $11M | $26M | $-20M | $-10M | $-693.0K | |
| EPS (Basic) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.36 | $-3.11 | $0.41 | $0.19 | $0.55 | $0.23 | $0.56 | $-0.43 | $-0.22 | $-0.02 | |
| EPS (Diluted) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.38 | $-3.11 | $0.39 | $0.19 | $0.58 | $0.23 | $0.51 | $-0.43 | $-0.19 | $-0.02 | |
| Shares (Basic) | 39,462,000 | 40,461,000 | · | 44,038,000 | 45,459,000 | 46,275,000 | · | 46,134,000 | 46,174,000 | 46,499,000 | · | 46,416,000 | 46,088,000 | 45,949,000 | · | 45,831,000 | |
| Shares (Diluted) | 40,300,000 | 40,910,000 | · | 44,459,000 | 45,459,000 | 46,526,000 | · | 46,134,000 | 50,539,000 | 52,193,000 | · | 52,067,000 | 52,054,000 | 45,949,000 | · | 45,831,000 | |
| EBITDA | $4M | $28M | · | $6M | $8M | $23M | · | $-140M | $28M | $32M | · | $18M | $40M | $17M | · | $21M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $206M | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M | $184M | · | $99M | $87M | $36M | · | $109M | |
| Short-term Investments | $45M | $58M | $80M | $99M | $145M | $210M | $208M | $208M | $157M | $142M | · | $136M | $134M | $138M | · | $219M | |
| Receivables | $132M | $126M | $124M | $115M | $114M | $105M | $113M | $101M | $105M | $102M | · | $97M | $99M | $93M | · | $93M | |
| Inventory | $135M | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M | $97M | · | $97M | $92M | $93M | · | $97M | |
| Prepaid Expense | $30M | $37M | $33M | $43M | $37M | $28M | $22M | $24M | $20M | $19M | · | $19M | $17M | $16M | · | $14M | |
| Current Assets | $615M | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M | $543M | · | $447M | $429M | $376M | · | $533M | |
| PP&E (Net) | $130M | $136M | $141M | $147M | $155M | $164M | $167M | $167M | $169M | $172M | · | $176M | $180M | $182M | · | $194M | |
| PP&E (Gross) | $281M | $281M | $278M | $280M | $308M | $304M | $300M | $297M | $293M | $292M | · | $307M | $308M | $305M | · | $295M | |
| Accum. Depreciation | $151M | $145M | $138M | $133M | $153M | $140M | $133M | $130M | $124M | $120M | · | $131M | $128M | $123M | · | $102M | |
| Goodwill | $20M | $20M | $20M | $20M | $20M | $22M | $0 | $0 | $163M | $163M | $163M | $163M | $163M | $163M | · | $157M | |
| Intangibles | $285M | $353M | $368M | $382M | $423M | $435M | $426M | $440M | $455M | $469M | · | $498M | $512M | $526M | · | $581M | |
| Total Assets | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Accounts Payable | $18M | $14M | $15M | $18M | $30M | $23M | $19M | $19M | $19M | $9M | · | $17M | $24M | $17M | · | $13M | |
| Accrued Liabilities | $93M | $85M | $96M | $80M | $71M | $80M | $80M | $76M | $65M | $67M | · | $60M | $56M | $62M | · | $76M | |
| Current Liabilities | $122M | $109M | $121M | $107M | $313M | $315M | $310M | $306M | $93M | $93M | · | $94M | $109M | $99M | · | $132M | |
| Capital Leases | $39M | $34M | $36M | $39M | $41M | $44M | $45M | $48M | $50M | $52M | · | $57M | $60M | $62M | · | $65M | |
| Deferred Tax | $4M | $4M | $4M | $5M | $5M | $7M | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $27M | $25M | $21M | $25M | $25M | $24M | $17M | $13M | $13M | $13M | · | $12M | $12M | $12M | · | $19M | |
| Total Liabilities | $572M | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M | $691M | · | $703M | $734M | $755M | · | $964M | |
| Long-term Debt | $363M | $368M | $372M | $377M | $580M | $583M | $585M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $363M | $368M | · | $377M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | · | $46.0K | $46.0K | $46.0K | · | $46.0K | |
| Paid-in Capital | $1.09B | $1.07B | $1.06B | $1.05B | $1.04B | $1.02B | $1.01B | $996M | $983M | $990M | · | $963M | $951M | $936M | · | $909M | |
| Retained Earnings | $-192M | $-196M | $-199M | $-201M | $-206M | $-202M | $-206M | $-222M | $-79M | $-98M | · | $-132M | $-143M | $-168M | · | $-139M | |
| Treasury Stock | $227M | $227M | $177M | $126M | $76M | $25M | $25M | $25M | $25M | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $4M | $4M | $4M | $1M | $343.0K | $678.0K | $105.0K | $152.0K | · | $-10.0K | $-173.0K | $-137.0K | · | $-670.0K | |
| Stockholders' Equity | $672M | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M | $892M | $870M | $832M | $808M | $768M | $775M | $770M | |
| Liabilities + Equity | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Shares Outstanding | 39,822,298 | 39,309,610 | 41,116,739 | 42,965,902 | 44,897,766 | 46,283,407 | 46,240,604 | 46,148,146 | 46,117,359 | 46,517,410 | 46,481,000 | 46,426,836 | 46,408,961 | 45,970,340 | 45,928,000 | 45,864,319 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21M | $21M | $21M | $21M | $27M | $21M | $21M | $20M | $19M | $18M | $18M | $18M | $19M | $20M | $30M | $20M | |
| Stock-based Comp | $15M | $14M | $13M | $14M | $15M | $15M | $12M | $13M | $13M | $13M | $12M | $13M | $11M | $12M | $13M | $13M | |
| Deferred Tax | · | · | $-4M | $8M | $752.0K | $1M | $4M | $1M | $13M | $3M | $7M | $5M | $11M | $-7M | $-11M | $702.0K | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Restructuring | · | · | $-54.0K | $4M | $0 | $0 | $808.0K | $1M | $996.0K | $6M | $0 | $173.0K | $936.0K | · | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-6M | · | · | · | $5M | · | · | · | $14M | · | · | |
| Operating Cash Flow | $57M | $26M | $44M | $61M | $12M | $35M | $33M | $54M | $53M | $49M | $48M | $44M | $43M | $19M | $42M | $43M | |
| CapEx | $1M | $3M | $218.0K | $4M | $3M | $9M | $2M | $4M | $2M | $3M | $2M | $3M | $3M | $7M | $5M | $5M | |
| Investing Cash Flow | $12M | $19M | $19M | $44M | $62M | $-26M | $-368.0K | $-52M | $-15M | $-16M | $8M | $-4M | $7M | $66M | $11M | $-48M | |
| Stock Repurchased | $0 | $50M | $48M | $50M | $50M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-8M | $-59M | $-52M | $-257M | $-58M | $-3M | $-2M | $-3M | $25M | $-3M | $-2M | $-28M | $440.0K | $-154M | $-59M | $-8M | |
| Net Change in Cash | $62M | $-14M | $11M | $-153M | $17M | $7M | $31M | $-1M | $63M | $31M | $54M | $12M | $51M | $-69M | $-5M | $-13M | |
| Taxes Paid | $860.0K | $50.0K | $69.0K | $711.0K | $8M | $286.0K | $1M | $5M | $5M | $-245.0K | $2M | $1M | $594.0K | $201.0K | · | $112.0K | |
| Free Cash Flow | · | $23M | · | · | · | $27M | · | · | · | $46M | · | · | · | $13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $44M | · | · | · | $5M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.2% | 3.9% | · | 3.5% | 4.7% | 1.2% | · | -82.8% | 15.9% | 7.9% | · | 10.8% | 23.5% | -1.9% | · | 12.7% | |
| Net Margin | 2.4% | 1.6% | · | 3.0% | -2.7% | 2.9% | · | -85.1% | 10.6% | 5.4% | · | 6.6% | 15.2% | -12.2% | · | -0.41% | |
| Pretax Margin | 1.3% | 2.8% | · | 5.3% | -1.1% | 5.1% | · | -82.4% | 20.5% | 8.2% | · | 10.1% | 22.3% | -16.5% | · | 1.2% | |
| EBITDA Margin | 2.2% | 15.9% | · | 3.5% | 4.7% | 13.7% | · | -82.8% | 15.9% | 18.9% | · | 10.8% | 23.5% | 10.3% | · | 12.7% | |
| ROA | 0.33% | 0.21% | · | 0.39% | -0.30% | 0.30% | · | -9.4% | 1.2% | 0.58% | · | 0.66% | 1.6% | -1.1% | · | -0.04% | |
| ROE | 0.65% | 0.40% | · | 0.74% | -0.59% | 0.57% | · | -18.1% | 2.2% | 1.1% | · | 1.4% | 3.3% | -2.6% | · | -0.09% | |
| ROIC | 0.75% | 0.39% | · | 0.33% | 2.8% | 0.14% | · | -19.2% | 1.7% | 0.97% | · | 1.4% | 3.4% | -0.30% | · | -0.93% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.7 | · | 5.3 | 2.4 | 2.4 | · | 2.3 | 6.8 | 5.8 | · | 4.8 | 3.9 | 3.8 | · | 4.1 | |
| Quick Ratio | 3.1 | 3.0 | · | 3.4 | 1.8 | 1.9 | · | 1.8 | 5.5 | 4.6 | · | 3.5 | 2.9 | 2.7 | · | 3.2 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.0 | · | 5.1 | 10.3 | -0.3 | · | 2.2 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.7 | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.7 | 1.8 | 1.7 | · | 2.3 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.87 | $16.63 | · | $16.93 | $16.88 | $17.25 | · | $16.24 | $19.07 | $19.18 | · | $17.91 | $17.41 | $16.71 | · | $16.79 | |
| Revenue / Share | $4.77 | $4.34 | · | $4.04 | $3.98 | $3.63 | · | $3.65 | $3.52 | $3.20 | · | $3.15 | $3.26 | $3.49 | · | $3.65 | |
| Cash Flow / Share | · | $0.63 | · | · | · | $0.76 | · | · | · | $0.94 | · | · | · | $0.42 | · | · | |
| Cash / Share | $5.17 | $3.67 | · | $3.44 | $6.69 | $6.13 | · | $5.33 | $5.36 | $3.96 | · | $2.13 | $1.87 | $0.77 | · | $2.39 | |
| EPS (TTM) | $0.36 | $0.13 | · | $0.49 | $-2.74 | $-2.24 | · | $-1.95 | $1.39 | $1.51 | · | $0.12 | $-0.13 | $-0.24 | · | $0.41 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $746M | $735M | · | $717M | $706M | $703M | · | $695M | $690M | $682M | · | · | · | · | · | $654M | |
| Net Income TTM | $15M | $5M | · | $21M | $-127M | $-104M | · | $-91M | $64M | $70M | · | $7M | $-5M | $-10M | · | $21M | |
| Market Cap | $1.01B | $888M | · | $1.11B | $1.07B | $1.15B | · | $695M | $1.32B | $1.36B | · | $1.42B | $1.86B | $1.88B | · | $2.44B | |
| Enterprise Value | $1.12B | $1.05B | · | $1.24B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 70.5 | 173.8 | · | 52.6 | -8.7 | -11.1 | · | -7.7 | 20.6 | 19.4 | · | 255.7 | -308.2 | -170.0 | · | 129.7 | |
| P/S | 1.4 | 1.2 | · | 1.5 | 1.5 | 1.6 | · | 1.0 | 1.9 | 2.0 | · | · | · | · | · | 3.7 | |
| P/B | 1.5 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 0.9 | 1.5 | 1.5 | · | 1.7 | 2.3 | 2.4 | · | 3.2 | |
| P / Tangible Book | 2.8 | 3.2 | · | 3.4 | 3.4 | 3.4 | · | 2.2 | 5.0 | 5.2 | · | 8.3 | 14.0 | 23.9 | · | 76.8 | |
| P / Cash Flow | · | 34.6 | · | · | · | 32.4 | · | · | · | 27.7 | · | · | · | 98.1 | · | · | |
| EV / Revenue | 1.5 | 1.4 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 1.4% | 0.58% | · | 1.9% | -11.5% | -9.0% | · | -13.0% | 4.9% | 5.2% | · | 0.39% | -0.32% | -0.59% | · | 0.77% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $726M | $701M | $675M | $667M | $542M |
| Marge d'exploitation % | 2.6% | · | 13.0% | 9.0% | 16.6% |
| Résultat net | $7M | $-100M | $42M | $16M | $42M |
| BPA dilué | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.5 | · | · | · | · |
| Ratio de liquidité | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 |
| Ratio de liquidité réduite | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $137M | $179M | $139M | $115M | $80M |
Détenteurs institutionnels (13F) 266 déclarants · $1.2B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
266
Valeur détenue
$1.2B
Nouvelles positions
36
Positions clôturées
23
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 36 (0 vs T. préc.) | 23 (-16 vs T. préc.) | 79 (-8 vs T. préc.) | 85 (+5 vs T. préc.) | +308K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $170 126 377 | 6 705 809 | 14,10% | Actions |
| VANGUARD GROUP INC | $124 559 276 | 4 812 955 | 10,32% | Actions |
| Doma Perpetual Capital Management LLC | $70 472 634 | 2 777 794 | 5,84% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $61 046 258 | 2 406 238 | 5,06% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $53 360 107 | 2 103 245 | 4,42% | Actions |
| STATE STREET CORP | $52 261 616 | 2 059 977 | 4,33% | Actions |
| D. E. Shaw & Co., Inc. | $49 479 923 | 1 950 332 | 4,10% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $43 986 531 | 1 733 801 | 3,65% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $42 915 156 | 1 691 571 | 3,56% | Actions |
| GOLDMAN SACHS GROUP INC | $38 743 263 | 1 527 129 | 3,21% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $29 401 072 | 1 158 693 | 2,44% | Actions |
| MORGAN STANLEY | $29 039 913 | 1 144 654 | 2,41% | Actions |
| AMERICAN CENTURY COMPANIES INC | $25 829 019 | 1 018 093 | 2,14% | Actions |
| UBS Group AG | $23 345 905 | 920 217 | 1,94% | Actions |
| Impax Asset Management Group plc | $19 028 185 | 750 027 | 1,58% | Actions |
| TWO SIGMA INVESTMENTS, LP | $18 383 203 | 724 604 | 1,52% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17 525 241 | 690 786 | 1,45% | Actions |
| GAGNON SECURITIES LLC | $15 440 613 | 608 617 | 1,28% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $14 294 929 | 563 458 | 1,18% | Actions |
| NORTHERN TRUST CORP | $13 364 459 | 526 782 | 1,11% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $10 436 533 | 411 373 | 0,87% | Actions |
| DEUTSCHE BANK AG\ | $9 922 232 | 391 101 | 0,82% | Actions |
| Jefferies Financial Group Inc. | $9 389 234 | 370 092 | 0,78% | Actions |
| Hillsdale Investment Management Inc. | $9 201 699 | 362 700 | 0,76% | Actions |
| Gagnon Advisors, LLC | $8 946 401 | 352 637 | 0,74% | Actions |
| JPMORGAN CHASE & CO | $8 698 627 | 346 697 | 0,72% | Actions |
| EASTERLY INVESTMENT PARTNERS LLC | $8 550 172 | 337 019 | 0,71% | Actions |
| Bridge City Capital, LLC | $7 922 975 | 312 297 | 0,66% | Actions |
| BARCLAYS PLC | $7 869 496 | 310 189 | 0,65% | Actions |
| Bank of New York Mellon Corp | $7 531 837 | 296 880 | 0,62% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $7 129 402 | 281 017 | 0,59% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $6 633 164 | 261 457 | 0,55% | Actions |
| Invesco Ltd. | $6 326 010 | 249 350 | 0,52% | Actions |
| BANK OF AMERICA CORP /DE/ | $6 088 952 | 240 006 | 0,50% | Actions |
| MILLENNIUM MANAGEMENT LLC | $5 966 085 | 235 163 | 0,49% | Actions |
| Coppell Advisory Solutions LLC | $5 592 970 | 16 | 0,46% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $5 562 474 | 219 254 | 0,46% | Actions |
| FMR LLC | $5 505 316 | 217 001 | 0,46% | Actions |
| Empowered Funds, LLC | $5 075 852 | 200 073 | 0,42% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $5 068 926 | 199 800 | 0,42% | Actions |
| ROYAL BANK OF CANADA | $4 704 000 | 185 433 | 0,39% | Actions |
| Banco Santander, S.A. | $4 211 420 | 166 000 | 0,35% | Actions |
| Robeco Institutional Asset Management B.V. | $4 161 036 | 164 014 | 0,34% | Actions |
| AMERIPRISE FINANCIAL INC | $4 137 744 | 163 096 | 0,34% | Actions |
| CITADEL ADVISORS LLC | $4 114 101 | 162 164 | 0,34% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $4 021 427 | 158 511 | 0,33% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3 562 811 | 140 434 | 0,30% | Actions |
| Public Sector Pension Investment Board | $3 429 720 | 135 188 | 0,28% | Actions |
| PDT Partners, LLC | $3 358 176 | 132 368 | 0,28% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $3 292 062 | 129 762 | 0,27% | Actions |
Activistes et détenteurs de 5%+ 16 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 dépôts | 12 mars 2026 | 7,30% | Amendement | Campagne de conseil d'administration | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 dépôts | 6 septembre 2019 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 18 mars 2014 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 26 juillet 2013 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 2 avril 2013 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 21 mars 2013 | · | Dépôt initial | · | SEC |
| Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 dépôts | 21 mars 2013 | · | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 28 septembre 2012 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 15 juin 2012 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 19 mars 2012 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 1 décembre 2011 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 1 décembre 2011 | · | Dépôt initial | Investissement passif | SEC |
| MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort | 29 novembre 2011 | · | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 18 février 2011 | · | Dépôt initial | · | SEC |
| Personne déclarante non divulguée | 18 février 2011 | · | Dépôt initial | · | SEC |
| MPM BioVentures IV Q-P, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski, Vaughn M. Kailian, John Vander Vort | 18 février 2011 | · | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 44 initiés · 20 dirigeants · 17 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frank D. Lee | Chief Executive Officer | 11 février 2026 A | 660 831 | 0 | 0 | $0 |
| David M Stack | CEO and Chairman | 14 juin 2023 A | 186 481 | 0 | 0 | $0 |
| Shawn Cross | Chief Financial Officer | 23 avril 2026 M | 105 341 | 0 | 7 | $-1 521 351 |
| Max Reinhardt | President, Rest of World | 7 juin 2023 S | 29 225 | 0 | 0 | $0 |
| James S Scibetta | President | 5 juin 2017 S | 25 118 | 0 | 0 | $0 |
| Scott Braunstein | Chief Operating Officer | 3 janvier 2018 A | 20 982 | 0 | 0 | $0 |
| Jonathan Slonin | Chief Medical Officer | 17 août 2026 S | 216 384 | 0 | 3 | $-240 431 |
| Lauren Riker | Senior Vice President, Finance | 11 juin 2026 S | 62 284 | 0 | 3 | $-261 266 |
| Kristen Williams | Chief Administrative Officer | 4 juin 2026 S | 167 062 | 0 | 2 | $-498 171 |
| Brendan Teehan | Chief Commercial Officer | 11 février 2026 A | 100 934 | 0 | 0 | $0 |
| Ronald J. Ellis Jr. | Chief Strategy Officer | 7 juin 2023 S | 30 909 | 0 | 0 | $0 |
| Dennis Mcloughlin | Chief Customer Officer | 7 juin 2023 S | 38 115 | 0 | 0 | $0 |
| Anthony Molloy | Chief Lgl & Compliance Officer | 6 juin 2023 S | 12 877 | 0 | 0 | $0 |
| Charles Anthony Laranjeira | Chief Technical Officer | 14 juin 2022 M | 41 752 | 0 | 0 | $0 |
| Richard Scranton | Chief Scientific Officer | 8 novembre 2019 M | 16 061 | 0 | 0 | $0 |
| Robert J. Weiland | Chief Commercial Officer | 4 juin 2018 S | 5 088 | 0 | 0 | $0 |
| James B Jones | SVP & Chief Medical Officer | 20 novembre 2017 S | 16 823 | 0 | 0 | $0 |
| Taunia Markvicka | SVP, Chief Commercial Officer | 17 mars 2015 M | 8 579 | 0 | 0 | $0 |
| Gary Patou | Chief Medical Officer | 7 août 2014 M | 0 | 0 | 0 | $0 |
| John Pratt | General Manager, San Diego | 13 juin 2013 M | 0 | 0 | 0 | $0 |
| Marcelo Bigal | Administrateur | 10 juin 2026 A | 17 798 | 0 | 0 | $0 |
| Alethia Young | Administrateur | 10 juin 2026 A | 17 798 | 0 | 0 | $0 |
| Christopher Christie | Administrateur | 10 juin 2026 A | 23 059 | 0 | 0 | $0 |
| Samit Hirawat | Administrateur | 10 juin 2026 A | 6 405 | 0 | 0 | $0 |
| Mark Froimson | Administrateur | 10 juin 2026 A | 26 541 | 0 | 1 | $-10 905 |
| Michael J. Yang | Administrateur | 10 juin 2026 A | 19 798 | 0 | 0 | $0 |
| Laura Brege | Administrateur | 10 juin 2026 A | 30 120 | 0 | 0 | $0 |
| Thomas G Wiggans | Administrateur | 10 juin 2026 A | · | 0 | 0 | $0 |
| Mark A. Kronenfeld | Administrateur | 11 juin 2025 A | 31 065 | 0 | 0 | $0 |
| Yvonne Greenstreet | Administrateur | 8 juin 2022 A | 13 247 | 0 | 0 | $0 |
| John P Longenecker PHD | Administrateur | 3 mars 2022 M | 18 823 | 0 | 0 | $0 |
| Andreas Wicki | Administrateur | 15 mars 2021 S | 451 324 | 0 | 0 | $0 |
| Dennis L Winger | Administrateur | 14 juin 2017 A | 7 490 | 0 | 0 | $0 |
| Fred A Middleton | Administrateur | 24 juin 2013 S | 0 | 0 | 0 | $0 |
| Luke Evnin | Administrateur | 12 juin 2013 A | 0 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Détenteur de 10% | 25 mars 2013 S | 2 233 993 | 0 | 0 | $0 |
| Abraham Ceesay | · | 4 septembre 2025 S | 9 039 | 0 | 0 | $0 |
| Daryl Gaugler | · | 31 décembre 2024 A | 115 443 | 0 | 0 | $0 |
| Charles A. Reinhart III | · | 12 juin 2024 A | 51 867 | 0 | 0 | $0 |
| Paul J Hastings | · | 12 juin 2024 A | 12 724 | 0 | 0 | $0 |
| Gary W Pace | · | 8 mars 2024 S | 22 127 | 0 | 0 | $0 |
| Roy Winston | · | 2 août 2023 S | 52 440 | 0 | 0 | $0 |
| Donald C. Manning | · | 9 juin 2021 A | 29 520 | 0 | 0 | $0 |
| GORDON CARL L | · | 8 février 2011 C | 2 828 941 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 58 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,28% | 10 029 NS | 31 juillet 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,74% | 8 394 NS | 31 juillet 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,55% | 37 961 SH | 2 octobre 2026 | Quotidien |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 4 607 SH | 2 octobre 2026 | Quotidien |
| RZG · Invesco Exchange-Traded Fund Trust | 0,50% | 23 694 SH | 2 octobre 2026 | Quotidien |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 27 368 SH | 2 octobre 2026 | Quotidien |
| SCOW · Pacer Funds Trust | 0,23% | 151 NS | 31 juillet 2026 | N-PORT |
| IHE · iShares Trust | 0,23% | 145 471 SH | 11 septembre 2026 | Quotidien |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 39 523 NS | 31 juillet 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,15% | 202 699 NS | 31 juillet 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,13% | 42 794 SH | 19 août 2026 | Quotidien |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 104 986 NS | 31 juillet 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,11% | 30 919 SH | 19 août 2026 | Quotidien |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,11% | 46 835 SH | 19 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 86 154 SH | 2 octobre 2026 | Quotidien |
| DFSV · Dimensional ETF Trust | 0,07% | 231 891 NS | 31 juillet 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,07% | 3 450 NS | 31 juillet 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 2 809 SH | 2 octobre 2026 | Quotidien |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,06% | 5 956 SH | 2 octobre 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 31 734 SH | 19 août 2026 | Quotidien |
| ROSC · Lattice Strategies Trust | 0,05% | 1 241 NS | 31 juillet 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 137 158 SH | 19 août 2026 | Quotidien |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,05% | 36 708 SH | 2 octobre 2026 | Quotidien |
| VFQY · VANGUARD WELLINGTON FUND | 0,04% | 7 883 SH | 19 août 2026 | Quotidien |
| DFAT · Dimensional ETF Trust | 0,04% | 204 980 NS | 31 juillet 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 18 945 NS | 31 juillet 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1 024 328 SH | 11 septembre 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 228 207 SH | 19 août 2026 | Quotidien |
| PKW · Invesco Exchange-Traded Fund Trust | 0,03% | 19 806 SH | 2 octobre 2026 | Quotidien |
| EBIT · Harbor ETF Trust | 0,02% | 106 NS | 31 juillet 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 542 974 SH | 19 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 2 098 SH | 2 octobre 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,02% | 90 095 NS | 31 juillet 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17 794 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 453 622 SH | 19 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,01% | 854 717 SH | 19 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 112 735 SH | 19 août 2026 | Quotidien |
| TILT · FlexShares Trust | 0,01% | 7 900 NS | 31 juillet 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2 019 SH | 11 septembre 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,01% | 118 628 NS | 31 juillet 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 1 277 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 6 433 NS | 31 juillet 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 28 461 SH | 11 septembre 2026 | Quotidien |
| DFAU · Dimensional ETF Trust | 0,00% | 9 932 NS | 31 juillet 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69 932 SH | 11 septembre 2026 | Quotidien |
| DFUS · Dimensional ETF Trust | 0,00% | 12 671 NS | 31 juillet 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12 150 SH | 11 septembre 2026 | Quotidien |
| DFUV · Dimensional ETF Trust | 0,00% | 866 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 198 792 SH | 19 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 506 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 388 SH | 19 août 2026 | Quotidien |
| IJR · iShares Trust | · | 2 397 496 SH | 10 septembre 2026 | Quotidien |
| IJT · iShares Trust | · | 374 609 SH | 9 septembre 2026 | Quotidien |
| IWN · iShares Trust | · | 338 098 SH | 11 septembre 2026 | Quotidien |
| XJR · iShares Trust | · | 5 453 SH | 31 août 2026 | Quotidien |
| ISCB · iShares Trust | · | 1 678 SH | 11 septembre 2026 | Quotidien |
| ISCV · iShares Trust | · | 8 216 SH | 11 septembre 2026 | Quotidien |
| SMMV · iShares Trust | · | 12 184 SH | 19 août 2026 | Quotidien |
PCRX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 13 analystes
ACHAT
Objectif médian
$30.00
+19,0%
3 23,1%
Achat fort
6 46,2%
Achat
3 23,1%
Conserver
1 7,7%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
9 analystes · 2026-10-01Objectif moyen $30.00 +19,0%
Maintenant
Prix actuel $25.21
Bas$23.00
Moyenne$30.00
Haut$38.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 4, 2026